4930452B06Rik Activators
4930452B06Rik Activators are a set of chemical compounds that trigger an enhanced functional activity of the 4930452B06Rik protein through various specific signaling pathways. Forskolin and Dibutyryl-cAMP are known to increase intracellular cAMP levels, which activates PKA, leading to phosphorylation events that could enhance the activities of downstream proteins including 4930452B06Rik. Similarly, by preventing the degradation of cAMP, IBMX indirectly maintains elevated levels of this messenger, potentiating PKA activity and potentially enhancing 4930452B06Rik function. PMA acts through the activation of PKC, a kinase that could phosphorylate 4930452B06Rik or related proteins, thereby enhancing 4930452B06Rik's role in cellular processes. Ionomycin and A23187 both function as calcium ionophores, raising intracellular calcium levels and activating calcium-dependent signaling pathways, which could lead to the activation of 4930452B06Rik if it plays a role in these pathways.
LY294002, by inhibiting PI3K, and PD98059 and U0126, by inhibiting MEK, may alter the balance of intracellular signaling, leading to a compensatory enhancement of pathways in which 4930452B06Rik is involved. SB203580 specifically inhibits p38 MAPK, potentially shifting signaling dynamics to support pathways that activate 4930452B06Rik. Genistein's inhibition of tyrosine kinases can reduce competitive signaling, potentially allowing for increased activity of alternative pathways that include 4930452B06Rik. Okadaic Acid, by inhibiting phosphatases, ensures proteins remain phosphorylated for longer periods, which could upregulate signaling pathways involving phosphorylated proteins, including 4930452B06Rik. Collectively, these chemical activators influence distinct signaling pathways that converge to enhance the functional activity of 4930452B06Rik, doing so without increasing its expression or directly binding to the protein, thus offering a multifaceted approach to upregulating its activity within cells.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor, which prevents the breakdown of cAMP and cGMP, thus indirectly increasing their levels within the cell. The resulting elevation in cAMP/cGMP can enhance the activity of PKA or PKG, respectively, and may thereby upregulate pathways involving the 4930452B06Rik protein. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can then modulate the function of various proteins by phosphorylation. By activating PKC, PMA may enhance the signaling pathways in which 4930452B06Rik is a component, thus increasing its functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, thereby activating calcium-dependent proteins and signaling pathways. Increased calcium signaling can enhance the activity of 4930452B06Rik if it is involved in calcium-dependent processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters the PI3K/Akt signaling pathway. By inhibiting PI3K, LY294002 can modulate downstream signaling which may include the activation of proteins or pathways that involve 4930452B06Rik, resulting in its enhanced activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that interferes with the MAPK/ERK pathway. Inhibition of MEK may lead to compensatory activation of alternative pathways or proteins, potentially increasing the activity of 4930452B06Rik if it is associated with such adaptive responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor which may redirect cellular signaling towards alternative pathways that could involve 4930452B06Rik, thereby enhancing its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, potentially activating calcium-binding proteins and associated signaling pathways that could enhance the activity of 4930452B06Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may enhance the activity of 4930452B06Rik by reducing competitive tyrosine kinase signaling, potentially allowing for increased activity of alternate signaling pathways involving 4930452B06Rik. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that can activate cAMP-dependent pathways by bypassing adenylyl cyclase. This direct elevation of cAMP-related signaling has the potential to enhance the activity of 4930452B06Rik through the activation of PKA and subsequent signaling cascades. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which leads to increased phosphorylation levels of various proteins. This inhibition can enhance signaling pathways that are positively regulated by phosphorylation, potentially increasing the functional activity of 4930452B06Rik. | ||||||